Berlin’s OpenHealth Technologies has secured $3 million in seed funding, a strong vote of confidence in its mission to unify fragmented health data.
The round was led by YZR Capital, with participation from GoHub Ventures, EdenBase, xdeck, and Exceptional Ventures. It saw continued support from existing investors, Octopus Ventures and calm/Storm Ventures.
This latest raise brings OpenHealth’s total funding to $4.3 Mn.
How OpenHealth plans to use the fresh funds
The fresh capital will fuel OpenHealth’s expansion across Europe and Latin America, targeting clinical labs, hospitals, insurers, pharma, and wellness brands.
A portion will also go toward advancing their AI-powered platform, building even smarter tools for preventive and personalised healthcare.
About OpenHealth
Founded in 2022 by CEO Gerrit Glass, Dr. Frederic Muench, and CTO Frank Krueger, OpenHealth set out to solve a painful industry challenge in healthcare: Billions of lab results trapped in siloed PDFs and disconnected systems.
Since lab results drive over 70% of clinical decisions, this fragmentation slows diagnoses, raises costs, and blocks the promise of precision medicine.
Their flagship solution, a central Lab Data API, is a data infrastructure layer for healthcare that powers:
- Data harmonisation: Cleaning and standardising messy lab data across formats and sources
- Data enrichment: Converting raw results into clinically meaningful insights
- Branded reporting: Delivering insights via white-label tools for patient portals, apps, and reports
Already, the platform harmonises more than 3,500 biomarkers and is fully GDPR/LGPD compliant.
Leadership and expertise
The founders bring a mix of personal motivation and technical depth.
As CEO Gerrit Glass explains, OpenHealth was born from “personal experience and a clear global need.” A frustration that inspired a platform to unlock the value of clinical data for preventive and personalised care.
Why investors are backing OpenHealth
For GoHub Ventures and others, OpenHealth’s timing is critical. As Pablo Perea, Partner at GoHub Ventures, put it:
“Their solution addresses a critical pain point in healthcare infrastructure. With the global push toward interoperability and patient-centred data, their timing and technology are spot on.”
That confidence is reinforced by the breadth of the investor group, signalling belief in OpenHealth’s potential to reshape lab data at scale.
Looking ahead
OpenHealth’s ambition is to become the core infrastructure for lab data worldwide, build the world’s largest structured biomarker database, impacting over 100 million lives!
With strong investor backing and a platform that blends AI with real clinical utility, they’re moving closer to a future where health data is finally unified, accessible, and impactful for millions.
-By Alkama Sohail and the AHT Team
